Report Detail

Chemical & Material Global Sodium Valproate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4522467
  • |
  • 14 March, 2023
  • |
  • Global
  • |
  • 112 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Sodium Valproate API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Sodium Valproate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Sodium Valproate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sodium Valproate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sodium Valproate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Sodium Valproate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sodium Valproate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sodium Valproate API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KATWIJK CHEMIE BV, SCI PHARMTECH INC, DUPONT NUTRITION BIOSCIENCES, SANOFI CHIMIE and ANJAN DRUG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Sodium Valproate API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Tablet
Injection
Capsule
Oral Solution
Syrup
Major players covered
KATWIJK CHEMIE BV
SCI PHARMTECH INC
DUPONT NUTRITION BIOSCIENCES
SANOFI CHIMIE
ANJAN DRUG
SUN PHARMACEUTICAL INDUSTRIES
ASSURGEN PHARMA
HARMAN FINOCHEM
Hunan Dino Pharmaceutical
Luzhou Creed Pharmaceutical
Shanghai Qingping Pharmaceutical
Jiangsu Hengrui Medicine
Hunan Xiangzhong Pharmaceutical
Renhetang Pharmaceutical
Shandong Fangming Pharmaceutical
Asahi Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sodium Valproate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sodium Valproate API, with price, sales, revenue and global market share of Sodium Valproate API from 2018 to 2023.
Chapter 3, the Sodium Valproate API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sodium Valproate API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sodium Valproate API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sodium Valproate API.
Chapter 14 and 15, to describe Sodium Valproate API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Sodium Valproate API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sodium Valproate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sodium Valproate API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tablet
    • 1.4.3 Injection
    • 1.4.4 Capsule
    • 1.4.5 Oral Solution
    • 1.4.6 Syrup
  • 1.5 Global Sodium Valproate API Market Size & Forecast
    • 1.5.1 Global Sodium Valproate API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Sodium Valproate API Sales Quantity (2018-2029)
    • 1.5.3 Global Sodium Valproate API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 KATWIJK CHEMIE BV
    • 2.1.1 KATWIJK CHEMIE BV Details
    • 2.1.2 KATWIJK CHEMIE BV Major Business
    • 2.1.3 KATWIJK CHEMIE BV Sodium Valproate API Product and Services
    • 2.1.4 KATWIJK CHEMIE BV Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 KATWIJK CHEMIE BV Recent Developments/Updates
  • 2.2 SCI PHARMTECH INC
    • 2.2.1 SCI PHARMTECH INC Details
    • 2.2.2 SCI PHARMTECH INC Major Business
    • 2.2.3 SCI PHARMTECH INC Sodium Valproate API Product and Services
    • 2.2.4 SCI PHARMTECH INC Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 SCI PHARMTECH INC Recent Developments/Updates
  • 2.3 DUPONT NUTRITION BIOSCIENCES
    • 2.3.1 DUPONT NUTRITION BIOSCIENCES Details
    • 2.3.2 DUPONT NUTRITION BIOSCIENCES Major Business
    • 2.3.3 DUPONT NUTRITION BIOSCIENCES Sodium Valproate API Product and Services
    • 2.3.4 DUPONT NUTRITION BIOSCIENCES Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 DUPONT NUTRITION BIOSCIENCES Recent Developments/Updates
  • 2.4 SANOFI CHIMIE
    • 2.4.1 SANOFI CHIMIE Details
    • 2.4.2 SANOFI CHIMIE Major Business
    • 2.4.3 SANOFI CHIMIE Sodium Valproate API Product and Services
    • 2.4.4 SANOFI CHIMIE Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 SANOFI CHIMIE Recent Developments/Updates
  • 2.5 ANJAN DRUG
    • 2.5.1 ANJAN DRUG Details
    • 2.5.2 ANJAN DRUG Major Business
    • 2.5.3 ANJAN DRUG Sodium Valproate API Product and Services
    • 2.5.4 ANJAN DRUG Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 ANJAN DRUG Recent Developments/Updates
  • 2.6 SUN PHARMACEUTICAL INDUSTRIES
    • 2.6.1 SUN PHARMACEUTICAL INDUSTRIES Details
    • 2.6.2 SUN PHARMACEUTICAL INDUSTRIES Major Business
    • 2.6.3 SUN PHARMACEUTICAL INDUSTRIES Sodium Valproate API Product and Services
    • 2.6.4 SUN PHARMACEUTICAL INDUSTRIES Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 SUN PHARMACEUTICAL INDUSTRIES Recent Developments/Updates
  • 2.7 ASSURGEN PHARMA
    • 2.7.1 ASSURGEN PHARMA Details
    • 2.7.2 ASSURGEN PHARMA Major Business
    • 2.7.3 ASSURGEN PHARMA Sodium Valproate API Product and Services
    • 2.7.4 ASSURGEN PHARMA Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 ASSURGEN PHARMA Recent Developments/Updates
  • 2.8 HARMAN FINOCHEM
    • 2.8.1 HARMAN FINOCHEM Details
    • 2.8.2 HARMAN FINOCHEM Major Business
    • 2.8.3 HARMAN FINOCHEM Sodium Valproate API Product and Services
    • 2.8.4 HARMAN FINOCHEM Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 HARMAN FINOCHEM Recent Developments/Updates
  • 2.9 Hunan Dino Pharmaceutical
    • 2.9.1 Hunan Dino Pharmaceutical Details
    • 2.9.2 Hunan Dino Pharmaceutical Major Business
    • 2.9.3 Hunan Dino Pharmaceutical Sodium Valproate API Product and Services
    • 2.9.4 Hunan Dino Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hunan Dino Pharmaceutical Recent Developments/Updates
  • 2.10 Luzhou Creed Pharmaceutical
    • 2.10.1 Luzhou Creed Pharmaceutical Details
    • 2.10.2 Luzhou Creed Pharmaceutical Major Business
    • 2.10.3 Luzhou Creed Pharmaceutical Sodium Valproate API Product and Services
    • 2.10.4 Luzhou Creed Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Luzhou Creed Pharmaceutical Recent Developments/Updates
  • 2.11 Shanghai Qingping Pharmaceutical
    • 2.11.1 Shanghai Qingping Pharmaceutical Details
    • 2.11.2 Shanghai Qingping Pharmaceutical Major Business
    • 2.11.3 Shanghai Qingping Pharmaceutical Sodium Valproate API Product and Services
    • 2.11.4 Shanghai Qingping Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Shanghai Qingping Pharmaceutical Recent Developments/Updates
  • 2.12 Jiangsu Hengrui Medicine
    • 2.12.1 Jiangsu Hengrui Medicine Details
    • 2.12.2 Jiangsu Hengrui Medicine Major Business
    • 2.12.3 Jiangsu Hengrui Medicine Sodium Valproate API Product and Services
    • 2.12.4 Jiangsu Hengrui Medicine Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Jiangsu Hengrui Medicine Recent Developments/Updates
  • 2.13 Hunan Xiangzhong Pharmaceutical
    • 2.13.1 Hunan Xiangzhong Pharmaceutical Details
    • 2.13.2 Hunan Xiangzhong Pharmaceutical Major Business
    • 2.13.3 Hunan Xiangzhong Pharmaceutical Sodium Valproate API Product and Services
    • 2.13.4 Hunan Xiangzhong Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Hunan Xiangzhong Pharmaceutical Recent Developments/Updates
  • 2.14 Renhetang Pharmaceutical
    • 2.14.1 Renhetang Pharmaceutical Details
    • 2.14.2 Renhetang Pharmaceutical Major Business
    • 2.14.3 Renhetang Pharmaceutical Sodium Valproate API Product and Services
    • 2.14.4 Renhetang Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Renhetang Pharmaceutical Recent Developments/Updates
  • 2.15 Shandong Fangming Pharmaceutical
    • 2.15.1 Shandong Fangming Pharmaceutical Details
    • 2.15.2 Shandong Fangming Pharmaceutical Major Business
    • 2.15.3 Shandong Fangming Pharmaceutical Sodium Valproate API Product and Services
    • 2.15.4 Shandong Fangming Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Shandong Fangming Pharmaceutical Recent Developments/Updates
  • 2.16 Asahi Pharmaceutical
    • 2.16.1 Asahi Pharmaceutical Details
    • 2.16.2 Asahi Pharmaceutical Major Business
    • 2.16.3 Asahi Pharmaceutical Sodium Valproate API Product and Services
    • 2.16.4 Asahi Pharmaceutical Sodium Valproate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Asahi Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Sodium Valproate API by Manufacturer

  • 3.1 Global Sodium Valproate API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Sodium Valproate API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Sodium Valproate API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Sodium Valproate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Sodium Valproate API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Sodium Valproate API Manufacturer Market Share in 2022
  • 3.5 Sodium Valproate API Market: Overall Company Footprint Analysis
    • 3.5.1 Sodium Valproate API Market: Region Footprint
    • 3.5.2 Sodium Valproate API Market: Company Product Type Footprint
    • 3.5.3 Sodium Valproate API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sodium Valproate API Market Size by Region
    • 4.1.1 Global Sodium Valproate API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Sodium Valproate API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Sodium Valproate API Average Price by Region (2018-2029)
  • 4.2 North America Sodium Valproate API Consumption Value (2018-2029)
  • 4.3 Europe Sodium Valproate API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Sodium Valproate API Consumption Value (2018-2029)
  • 4.5 South America Sodium Valproate API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Sodium Valproate API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 5.2 Global Sodium Valproate API Consumption Value by Type (2018-2029)
  • 5.3 Global Sodium Valproate API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 6.2 Global Sodium Valproate API Consumption Value by Application (2018-2029)
  • 6.3 Global Sodium Valproate API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 7.2 North America Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 7.3 North America Sodium Valproate API Market Size by Country
    • 7.3.1 North America Sodium Valproate API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Sodium Valproate API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Sodium Valproate API Market Size by Country
    • 8.3.1 Europe Sodium Valproate API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Sodium Valproate API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Sodium Valproate API Market Size by Region
    • 9.3.1 Asia-Pacific Sodium Valproate API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Sodium Valproate API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 10.2 South America Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 10.3 South America Sodium Valproate API Market Size by Country
    • 10.3.1 South America Sodium Valproate API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Sodium Valproate API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sodium Valproate API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Sodium Valproate API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Sodium Valproate API Market Size by Country
    • 11.3.1 Middle East & Africa Sodium Valproate API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Sodium Valproate API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Sodium Valproate API Market Drivers
  • 12.2 Sodium Valproate API Market Restraints
  • 12.3 Sodium Valproate API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sodium Valproate API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sodium Valproate API
  • 13.3 Sodium Valproate API Production Process
  • 13.4 Sodium Valproate API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sodium Valproate API Typical Distributors
  • 14.3 Sodium Valproate API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sodium Valproate API. Industry analysis & Market Report on Sodium Valproate API is a syndicated market report, published as Global Sodium Valproate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Sodium Valproate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,784.00
    4,176.00
    5,568.00
    3,250.32
    4,875.48
    6,500.64
    547,508.40
    821,262.60
    1,095,016.80
    290,197.20
    435,295.80
    580,394.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report